Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial

Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T13:56:54.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has removed extensive details about a clinical study involving entinostat and pembrolizumab for various cancers, while adding new identifiers and collaborators related to the study.
    Difference
    30%
    Check dated 2025-04-16T02:08:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.
    Difference
    0.1%
    Check dated 2025-04-08T23:48:56.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has updated its posting dates and revision number, indicating a more recent version of the content. The estimated dates have been replaced with specific dates, which may reflect more accurate information.
    Difference
    0.1%
    Check dated 2025-04-01T18:51:09.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to include detailed information about a Phase 1b/2 study of entinostat combined with pembrolizumab for treating non-small cell lung cancer (NSCLC), melanoma, and colorectal cancer, including specific eligibility criteria and treatment protocols. Additionally, new results reporting dates and study documentation have been added.
    Difference
    90%
    Check dated 2025-03-25T13:16:06.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-03-03T22:25:38.000Z thumbnail image

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.